Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

The possibility of re-infection is often cited as a reason for not initiating treatment in injection drug users (IDUs). Recent observational data suggest that the rate of re-infection may be reduced following spontaneous or treatment-induced virologic clearance, although such data are often retrospective and incomplete. Supplement: Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection http://www.biomedcentral.com/content/pdf/1758-2652-13-S4-info.pdf Conference: Tenth International Congress on Drug Therapy in HIV Infection 7-11 November 2010 Glasgow, UK (Published: 8 November 2010) doi:10.1186/1758-2652-13-S4-P199 Cite this article as: Conway et al.: Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users. Journal of the International AIDS Society 2010 13(Suppl 4):P199. Full text: PubMed Central:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112981/